Amana Biomedical And Health Technology is categorized under Health Services in Iowa City, IA and active since 2008.
Amana Biomedical And Health Technology was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Mohammed Filali at the company’s single location by writing to 2343 Kristian St, Iowa City, Iowa IA 52240 or by phoning (319) 351-9514. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Amana Biomedical And Health Technology |
| Contact Person: | Mohammed Filali |
| Address: | 2343 Kristian St, Iowa City, Iowa 52240 |
| Phone Number: | (319) 351-9514 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Amana Biomedical And Health Technology was started in 2008 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mohammed Filali for inquiries that concern Amana Biomedical And Health Technology by calling the company number (319) 351-9514, as your correspondence is most welcome. Additionally, the physical location of the single location of Amana Biomedical And Health Technology can be found at the coordinates as well as the street address 2343 Kristian St in Iowa City, Iowa 52240.
For its online presence, you may visit Amana Biomedical And Health Technology’s website at and engage with its social media outlets through on Twitter and on Facebook.